imatinib mesylate has been researched along with Hoarseness in 1 studies
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 0 (0.00) | 18.2507 |
| 2000's | 0 (0.00) | 29.6817 |
| 2010's | 0 (0.00) | 24.3611 |
| 2020's | 1 (100.00) | 2.80 |
| Authors | Studies |
|---|---|
| Bindal, P; Noor, A; Ramirez, M; Vredenburgh, J | 1 |
1 review(s) available for imatinib mesylate and Hoarseness
| Article | Year |
|---|---|
Chordoma: A Case Report and Review of Literature.
Topics: Afatinib; Aged; Antineoplastic Agents; Chordoma; Combined Modality Therapy; Female; Head and Neck Neoplasms; Hoarseness; Humans; Imatinib Mesylate; Magnetic Resonance Imaging; Neoplasm Recurrence, Local; Spinal Neoplasms | 2020 |